Pfizer’s celebrated Covid-19 vaccine freezes many people out but a rival mRNA team says they thawed out a solution – Endpoints News

Less than four months after a $55 million raise, Seer is ready to go public.

The company, run by Omid Farokhzad, filed for a $150 million IPO on Thursday as it prepares to jump onto the Nasdaq. Seers stock ticker will be fairly simple to remember $SEER and the move comes after the company has raised more than $150 million since being founded in 2017.

Thursdays news also comes less than a month after Seers main product, the Proteograph Product Suite, was delivered to one of its first collaborators, per the companys S-1. Funds from the IPO will go toward further commercializing the product and other R&D-related projects for Proteograph.

Read More

Continue reading here:

Pfizer's celebrated Covid-19 vaccine freezes many people out but a rival mRNA team says they thawed out a solution - Endpoints News

Related Posts
Tags: